Omega-3 Fish Oil vs Krill Oil: Which is the Superior Source?

Fish Oil (Omega-3)

Standard fish oil (from anchovy, sardine, mackerel) provides EPA and DHA as triglycerides or, in many concentrated products, ethyl esters. A typical 1000 mg fish oil softgel contains 180 mg EPA + 120 mg DHA — providing 300 mg combined omega-3s per capsule. High-quality concentrated fish oils can provide 600–800 mg combined EPA+DHA per capsule. The REDUCE-IT trial, which used high-dose EPA (icosapentaenoic acid as Vascepa/Epanova at 4 g/day), demonstrated a landmark 25% reduction in cardiovascular events — establishing very high-dose omega-3 as a significant cardiovascular intervention.

Krill Oil

Krill oil typically contains lower absolute amounts of EPA+DHA per capsule (150–250 mg combined per 500 mg krill oil capsule) but delivers them as phospholipids (predominantly phosphatidylcholine-bound). The phospholipid form is absorbed differently — partially bypassing the lymphatic chylomicron pathway and entering portal circulation directly. This reportedly improves bioavailability by 40–100% versus equivalent doses of triglyceride fish oil, potentially making lower absolute doses therapeutically equivalent. However, demonstrating bioequivalence requires careful dosing calculations.

Fish Oil (Omega-3)

The cardiovascular evidence for fish oil is the most developed in nutrition pharmacology. Beyond REDUCE-IT, multiple large meta-analyses (including a 2019 Cochrane review of 79 RCTs, n>112,000) confirm omega-3 supplementation reduces triglycerides, slightly reduces cardiovascular events, and modestly reduces all-cause mortality. High-dose EPA appears superior to EPA+DHA combinations for cardiovascular outcomes based on REDUCE-IT vs STRENGTH trial comparisons. The recent VITAL trial also showed omega-3 supplementation reduced cardiovascular events in non-supplementing adults.

Krill Oil

Krill oil cardiovascular data are far fewer — primarily smaller studies and animal work. A few human studies show similar or slightly superior lipid-modifying effects per mg of omega-3 compared to fish oil (supporting the bioavailability argument), but no large outcome trial has been conducted with krill oil. The lack of a REDUCE-IT equivalent for krill oil means its cardiovascular benefit beyond lipid markers remains inferred rather than demonstrated.

Fish Oil (Omega-3)

DHA is the predominant omega-3 in brain tissue and retina, accounting for ~40% of the fatty acids in brain grey matter. Fish oil supplementation raises plasma DHA levels, but brain DHA enrichment is a slow process requiring sustained supplementation. The most relevant fish oil for brain health is a DHA-concentrated formulation rather than a balanced EPA:DHA product. For children and pregnant women, DHA from fish oil is particularly critical — supported by strong clinical evidence.

Krill Oil

Krill oil's phospholipid delivery form has been specifically proposed to enhance brain DHA distribution. Lysophosphatidylcholine-DHA (LPC-DHA), formed during krill oil digestion, uses a dedicated brain transport mechanism (Mfsd2a transporter) that may be more efficient than the free DHA pathway used by fish oil-derived DHA. Some animal studies support superior brain DHA enrichment with phospholipid omega-3 versus triglyceride forms. Human neuroimaging studies confirming this advantage are ongoing but limited.

Fish Oil (Omega-3)

Fish oil is highly susceptible to oxidation, which produces toxic aldehydes and peroxides that may negate health benefits. A significant proportion of commercial fish oil products are oxidised beyond recommended thresholds. Freshness indicators (peroxide value, anisidine value, TOTOX score) vary widely across brands. Consuming high-quality, freshly manufactured fish oil from companies with third-party testing (e.g., IFOS certification) is essential. Addition of vitamin E (tocopherol) as an antioxidant is common but may be insufficient for low-quality products.

Krill Oil

Krill oil contains astaxanthin, a potent carotenoid antioxidant naturally present in krill, which stabilises the phospholipid omega-3s and substantially reduces oxidation susceptibility. This natural oxidation protection gives krill oil a significant shelf-life and quality advantage over fish oil — meaning the omega-3s reaching target tissues are more likely to be intact and unoxidised. This is a genuine differentiating advantage of krill oil that partially offsets its higher cost.

Fish Oil (Omega-3)

Fish oil sourced from small pelagic fish (anchovies, sardines) has a moderate environmental footprint. The Omega-3 Index (a validated biomarker of omega-3 status) responds to both fish oil and dietary fish consumption, but fish oil allows therapeutic dosing. MSC certification and sustainable sourcing vary by brand. Vegan alternatives (algae-derived DHA/EPA) are increasingly available and environmentally superior, providing the same omega-3s from the original source (algae are what make fish rich in omega-3s).

Krill Oil

Antarctic krill (Euphausia superba) is the largest biomass of any animal species on Earth and is harvested under strict international quota management (CCAMLR convention). However, krill are foundational to the Antarctic food web (whales, penguins, seals), and environmental groups debate whether current harvest levels are sustainable as climate change reduces krill habitat. The sustainability picture is complex and actively evolving.